Cleared Traditional

K852032 - OCULAR PRESSURE REDUCER (MCCANNEL)

K852032 is an FDA 510(k) clearance for OCULAR PRESSURE REDUCER (MCCANNEL), manufactured by Visitec Co.. The device is a Class 2 Ophthalmic device with product code LCC cleared through the Traditional 510(k) pathway after a 95-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1985
Decision
95d
Days
Class 2
Risk

K852032 is an FDA 510(k) clearance for the OCULAR PRESSURE REDUCER (MCCANNEL). Classified as Applicator, Ocular Pressure (product code LCC), Class II - Special Controls.

Submitted by Visitec Co. (Sarasota, US). The FDA issued a Cleared decision on August 12, 1985 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4610 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Visitec Co. devices

FDA 510(k) Submission Details - K852032

510(k) Number K852032 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 1985
Decision Date August 12, 1985
Days to Decision 95 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 110d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCC Device Classification - Class 2, Special Controls

Product Code LCC Applicator, Ocular Pressure
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4610
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.